SeoulMarkets · tag
supply-contract
6 stories tagged “supply-contract”, each from official Korean data with its source and timestamp.
A 2021 Drama Licensing Deal Was Kept Secret for Five Years. The Embargo Just Ended.
Samhwa Networks signed a $5.6 million global streaming license for its drama Now, Showtime! in 2021 and was allowed to withhold the amount. The filing disclosing it, five years later, states why: the embargo period ran out.
A Coupang Robotics Contract Shrank by 40% — After the Work Was Done
CMES Robotics disclosed a ₩1.19 billion Coupang warehouse-automation contract as 17.2% of revenue. Its amendment, filed after the contract ended, revises it down to ₩713 million — 10.34% — the amount actually collected.
Namhwa Construction Amended a ₩7.68 Billion Contract — Only the Timeline Changed
Namhwa Construction's supply contract with Daegwang Community Credit Cooperative, worth 13.56% of revenue, was amended on 23 September. The filing states only the contract period changed — the amount did not.
Spear Won't Name Its Aerospace Customer. The Filing Still Gives Up 12%.
Spear disclosed an ₩11.58 billion special-alloy contract worth 12.1% of revenue. The counterparty is withheld, described only as a 'US global aerospace launch company' — but the amount and ratio are not.
Hyundai Rotem's Taiwan Rail Contract Is 5.9% of Last Year's Revenue
A ₩344.5 billion supply contract with Taiwan's Taoyuan Department of Rapid Transit Systems runs through October 2034 — eight years, filed the same day as two other same-industry disclosures.
SK Biopharmaceuticals Signed a 9% Supply Contract — With Its Own Subsidiary
The ₩63.3 billion deal names SK Life Science, Inc. as the counterparty, and the filing states the relationship: SK Biopharmaceuticals' own subsidiary. The filing ties it to XCOPRI, the company's US-marketed epilepsy drug.